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the Student t test based on the normality of distribution. Bonferroni correction was used for multiple comparisons. All statistical analyses were conducted using SAS software, version 9.3 (SAS Institute, Inc, Cary, NC).
Results
Nineteen patients with asymptomatic carotid stenosis and 15 patients with symptomatic disease were enrolled. Both groups were similar in terms of baseline characteristics, including previous transient ischemic attack/stroke unrelated to the current carotid lesion, antiplatelet therapy, statin use, and carotid artery peak systolic velocity. CEA represented primary intervention in all patients, none of whom had had previous cervical radiation therapy. Symptomatic patients displayed a variety of clinical manifestations (Table) . Body mass index was similar between groups. Spearman correlation revealed a trend toward a negative correlation between perivascular adiponectin and body mass index (r=−0.38; P=0.03), which was not significant after Bonferroni correction, as well as a significant positive correlation between leptin and body mass index (r=0.59; P=0.0003).
Comparison of symptomatic versus asymptomatic patients revealed that the former had 1.9-fold higher perivascular adiponectin (P=0.005; Figure 1 ; Table I in the online-only Data Supplement). This association was robust, remaining statistically significant after Bonferroni adjustment (α/9=0.006). Symptomatic patients demonstrated trends toward (1) plasma IL-1β decrease (2.7-fold; P=0.008), (2) subcutaneous adiponectin elevation (1.5-fold; P=0.04), and plasminogen activator inhibitor-1 decrease (2-fold; P=0.01), and (3) perivascular IL-1β elevation (1.4-fold; P=0.015; Tables I-III in the onlineonly Data Supplement) .
Endarterectomy specimen pathological scoring did not differ between symptomatic and asymptomatic patients ( Figure 2 ; Table IV in the online-only Data Supplement). There were no significant differences between perivascular mediator levels and histological characteristics.
Discussion
Here, we find that perivascular adiponectin expression differs based on symptom status in patients undergoing CEA. This differential expression profile was only present in the perivascular compartment-symptomatic patients had similar circulating adiponectin levels when compared with their asymptomatic counterparts but had significantly higher adiponectin expression in tissue contiguous to the carotid artery. There were several other adipose-related biomarker trends between these small cohorts, further supporting potential signaling pathways between the vasculature and these tissues.
Little data exist on perivascular adiponectin in humans. In a previous report, we did note decreased perivascular adiponectin compared with the subcutaneous compartment in major leg amputation specimens. 9 Decreased plasma adiponectin levels have been found to be associated with increased coronary artery atherogenesis, plaque vulnerability, and carotid intima-media thickness. [10] [11] [12] Here, a seemingly paradoxical relationship was found between local perivascular adiponectin (traditionally viewed as a protective vascular mediator) and symptom status (a clinical marker of destabilized plaque). 1, 2 This may suggest disparate roles for local versus systemic adiponectin or undefined effects of adiponectin.
In this cohort, pathological characteristics of carotid plaques were similar between symptomatic and asymptomatic patients. The observation that perivascular expression of adiponectin was significantly associated with symptom status 
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whereas plaque histology was not supports that the former association has a larger effect size. Note that carotid plaques are complex, and the microscopic analyses may have sampling errors. Alternatively, local adiponectin expression and symptom development may be linked via plaque destabilization-independent mechanisms. Limitations are acknowledged. In total, we obtained singleperivascular adipose samples from 34 patients. Assuming a type I error rate α equals to 0.05 and type II error rate β equals to 0.10 (90% power), our study is powered to detect effect sizes of 0.6; subtle differences in protein levels can be missed, and the interesting trends noted in the other mediators may be biologically noteworthy. Type I error (eg, in the association seen between symptom status and perivascular adiponectin) was addressed by Bonferroni correction. Nearly all of our patients were whites, which may limit the generalizability of our results. The duration of plaque-stabilizing medication use and compliance in each group were not clear from our source data. The current piece examines beyond the vessel wall to the surrounding adipose; thus, detailed plaque morphology (complete plaque sectioning with search for intraplaque hemorrhage) was not the focus of the study because knowledge relating plaque characteristics and symptoms is widely accepted. We do include some basic plaque morphology data because it may relate to the adipose phenotype. Most importantly, precise mechanisms cannot be derived from this observational data, although the novel associations discovered should spur such important studies.
Conclusions
Symptomatic CEA patients exhibit 2-fold higher local, perivascular adipose adiponectin levels. This novel link suggests previously unrecognized relationships among the neurological, vascular, and adipose organs, and it may lead to strategies to improve patient selection and other measures for stroke risk reduction.
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Supplemental Methods
Methods for protein assay from subcutaneous and perivascular adipose tissues have been described previously. 1 At the time of surgery, peripheral blood, subcutaneous adipose tissue (at the site of the cervical incision), and perivascular adipose tissue (contiguous to the adventitia of the diseased common and internal carotid arteries) of patients undergoing carotid endarterectomy (CEA) were obtained by six participating surgeons who had been briefed on the standardized sampling techniques. Fifteen milliliters of peripheral blood were obtained at the time of peripheral intravenous line placement and plasma was isolated by centrifugation for 15 minutes at 2000g at room temperature. Surgeons performing the carotid endarterectomy collected 50 to 500 milligrams of adipose tissue from each of two locations: (1) subcutaneous tissue at the site of neck incision, and (2) perivascular tissue contiguous to the adventitia of diseased segments of the operative carotid artery. All samples were immediately flash frozen in liquid nitrogen then stored at -80 o C until the time of analysis. Proteins were isolated from the samples using ice-cold Dulbecco's phosphate-buffered saline with protease inhibitor cocktail (Roche Applied Science, Indianapolis, IN). This solution was then homogenized and centrifuged (2,000g x 5 minutes) to remove gross debris. Homogenates were again centrifuged (10,000g x 10 minutes). The supernatant was then collected for quantitative protein analysis using a Luminex multiple antigen flow microparticle bead assay (Luminex Corporation, Austin, TX). Based on previous literature, nine key biologic mediators were assayed: adiponectin, interleukin (IL)-1, IL-6, IL-8, leptin, monocyte chemoattractant protein (MCP)-1, plasminogen activator inhibitor (PAI)-1, resistin, and tumor necrosis factor (TNF). [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Quantities were adjusted by the total volume of each sample. 
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